Why it was recalled
Presence of Particulates; may contain glass particles
Product description
Epinephrine Injection USP, 1 mL, USP 1:1000 (1 mg/mL), SQ/IM, Hospira, Inc., Lake Forest, IL --- NDC 0409-7241-01
Lot numbers, UPCs & expiration codes
Lot 100953A, Exp 01OCT2013; Lot 120803A Exp 01DEC2013
Where it was sold
Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-106-2013
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Oct 25, 2012
- FDA report date
- Jan 9, 2013
- Quantity
- 361,600/1-mL ampules
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Hospira Inc.
Original FDA data
Every field from FDA enforcement report D-106-2013, exactly as published.
Show all FDA fields
- City
- Lake Forest
- State
- IL
- Status
- Terminated
- Country
- United States
- Event ID
- 63589
- Address
- 275 N Field Dr
- Code information
- Lot 100953A, Exp 01OCT2013; Lot 120803A Exp 01DEC2013
- Postal code
- 60045-2579
- Report date
- Jan 9, 2013
- Product type
- Drugs
- Recall number
- D-106-2013
- Classification
- Class II
- Recalling firm
- Hospira Inc.
- Product quantity
- 361,600/1-mL ampules
- Termination date
- Oct 15, 2014
- Reason for recall
- Presence of Particulates; may contain glass particles
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Epinephrine Injection USP, 1 mL, USP 1:1000 (1 mg/mL), SQ/IM, Hospira, Inc., Lake Forest, IL --- NDC 0409-7241-01
- Distribution pattern
- Nationwide
- Recall initiation date
- Oct 25, 2012
- Initial firm notification
- Letter
- Center classification date
- Dec 28, 2012